PTGS2 and metastatic malignant neoplasm in the lymph nodes: For validation at the experimental level, the expression of PTGS2, MET, and ICAM1 was analyzed via immunohistochemical staining of pathological sections from the lymph node metastasis and non-metastasis groups.